Barclays PLC Intercept Pharmaceuticals, Inc. Put Options Transaction History

Barclays PLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2020 May 13, 2020	SELL	$48.35 - $118.68 $4,835 - $11,868	-100 Reduced 9.09%	1,000 $63,000
Q4 2019 Feb 10, 2020	SELL	$57.36 - $124.1 $68,832 - $148,920	-1,200 Reduced 52.17%	1,100 $136,000
Q3 2019 Nov 14, 2019	BUY	$58.69 - $80.46 $70,428 - $96,551	1,200 Added 109.09%	2,300 $153,000
Q2 2019 Aug 14, 2019	SELL	$77.77 - $120.68 $15.8 Million - $24.5 Million	-202,700 Reduced 99.46%	1,100 $88,000
Q1 2019 May 15, 2019	BUY	$91.83 - $120.68 $15 Million - $19.7 Million	163,500 Added 405.71%	203,800 $22.8 Million
Q4 2018 Feb 14, 2019	BUY	$85.79 - $126.46 $17,158 - $25,292	200 Added 0.5%	40,300 $4.06 Million
Q3 2018 Nov 14, 2018	BUY	$88.49 - $127.55 $8,849 - $12,755	100 Added 0.25%	40,100 $5.07 Million
Q2 2018 Aug 14, 2018	BUY	$60.0 - $85.67 $894,000 - $1.28 Million	14,900 Added 59.36%	40,000 $3.36 Million
Q3 2017 Nov 14, 2017	BUY	$57.01 - $118.75 $1.43 Million - $2.98 Million	25,100	25,100 $1.46 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.